Cargando…
Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection
Direct-acting antivirals (DAAs) have dramatically improved the management of chronic hepatitis C (CHC). In this study, we investigated the effects of hepatitis C virus clearance on markers of systemic inflammation measured in plasma samples from CHC patients before, during and after DAA therapy. We...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005788/ https://www.ncbi.nlm.nih.gov/pubmed/32034167 http://dx.doi.org/10.1038/s41598-020-58768-z |